Complications and Red Flags
At a Glance
AA amyloidosis red flags include sudden breathing trouble, chest pain, fainting, confusion, severe swelling, much less urine, black stools, or vomiting blood. Immune-modifying medicines and steroids can hide fever, so rapidly worsening symptoms need urgent medical care.
While most people with AA amyloidosis experience a slow, manageable progression of the disease, there are instances where the condition or its treatment requires urgent attention. Recognizing these signs is not about living in fear; it is about knowing when to stop managing at home and seek immediate medical care [1][2].
Acute Kidney Injury and Nephrotic Complications
Rarely, patients can experience rapid, severe worsening of kidney function or severe nephrotic complications—a scenario sometimes described in medical literature as an “amyloid storm” [2][3]. This is often triggered by a severe infection or a massive flare of the underlying inflammatory disease.
- The Signs: You may notice a sudden, massive increase in swelling (edema), extremely foamy urine, a sharp drop in how much you are urinating, or severe breathlessness [3].
- The Danger: A rapid loss of kidney function or massive fluid overload requires urgent hospital assessment. It can lead to dangerous imbalances and may require aggressive therapy or dialysis [3][2].
Drug-Induced Kidney Injury (aTIN)
People with AA amyloidosis are at risk for a complication called acute tubulointerstitial nephritis (aTIN) [4]. This is an allergic-like reaction in the kidneys, usually triggered by a medication.
- Common Culprits: Antibiotics, proton-pump inhibitors (PPIs) for reflux, and NSAIDs (like ibuprofen) are common triggers [5][6].
- The Warning Signs: You may develop a fever, a new rash, or joint pain, though many people simply have a sudden, unexplained rise in their creatinine levels on blood tests [6][5].
- The Risk: In small biopsy cohorts, patients with AA amyloidosis who developed aTIN had high rates of progressing to dialysis [4]. A sudden creatinine rise requires prompt evaluation, but do not stop an essential antibiotic, PPI, or other prescribed drug on your own—always contact your clinician first.
Serious Infections on Biologics
Because treatments like IL-6 or IL-1 inhibitors work by modifying your immune system, they make you more vulnerable to severe infections [7][8].
- Masked Symptoms: Biologics and steroids can blunt your body’s ability to produce a fever or raise your CRP, meaning you can be very sick without a high temperature [9].
- Sepsis: Seek emergency care for confusion, severe breathing difficulty, fainting, rapidly worsening weakness, or blue lips. Do not wait to monitor these at home [8][10].
- Tuberculosis (TB): Biologics can reactivate dormant TB. Report any persistent cough, night sweats, or unexplained weight loss [11].
Gastrointestinal Bleeding
If amyloid deposits settle in the walls of your stomach or intestines, it can make the tissue fragile and prone to bleeding [12]. Seek immediate care for:
- Black or tarry stools (a sign of bleeding high in the gut).
- Vomiting blood or material that looks like coffee grounds.
- Severe abdominal distension or severe, unyielding abdominal pain [13].
When to Seek Urgent Care
Knowing the boundaries of when to wait and when to act is crucial. “Stable” symptoms (like mild foamy urine that your doctor is already monitoring) are a routine management issue. However, new or rapidly worsening symptoms are not.
Seek urgent medical care if you experience:
- Sudden shortness of breath or chest pain.
- Fainting or severe dizziness.
- New, severe swelling, especially if it is one-sided.
- A dramatic reduction in your urine output.
- Severe allergic reactions or sudden confusion.
Always trust your instincts: if something feels “different” or “fast,” contact your specialty team or go to the nearest emergency room. [3]
Common questions in this guide
What are the emergency warning signs of AA amyloidosis?
Can AA amyloidosis cause sudden kidney failure?
Which medicines can cause kidney injury in AA amyloidosis?
Can biologic medicines hide a serious infection?
What could black stools or vomiting blood mean in AA amyloidosis?
How can I tell a routine flare from a serious AA amyloidosis complication?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If I experience a sudden increase in swelling or foamy urine, what is our action plan for getting me evaluated quickly?
- 2.Which of my current medications could potentially trigger kidney injury, and should I stop any of them if my creatinine rises?
- 3.Since I am on an immunomodulating medication, what specific symptoms should prompt me to seek emergency care?
- 4.How will we distinguish between a normal flare of my primary disease and a serious complication of the amyloidosis?
- 5.What are the early warning signs of GI involvement, and at what point should I seek an urgent evaluation?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
French practical guidelines for the diagnosis and management of AA amyloidosis.
Georgin-Lavialle S, Savey L, Buob D, et al.
La Revue de medecine interne 2023; (44(2)):62-71 doi:10.1016/j.revmed.2022.12.004.
PMID: 36759076 - 2
Amyloid storm: acute kidney injury and massive proteinuria, rapidly progressing to end-stage kidney disease in AA amyloidosis of familial Mediterranean fever.
Kukuy OL, Beckerman P, Dinour D, et al.
Rheumatology (Oxford, England) 2021; (60(7)):3235-3242 doi:10.1093/rheumatology/keaa772.
PMID: 33291151 - 3
From ulcerative colitis to amyloid storm: a case-based review.
Özkurt S, Cansu DÜ, Yildirim U, et al.
Rheumatology international 2025; (45(11)):263 doi:10.1007/s00296-025-06015-x.
PMID: 41165831 - 4
Dismal Prognosis of Acute Allergic Tubulointerstitial Nephritis in Patients with AA Amyloidosis.
Yildirim T, Gok-Oguz E, Koc NS, et al.
Nephron 2022; (146(2)):172-178 doi:10.1159/000520151.
PMID: 34852341 - 5
Medication-Induced Interstitial Nephritis in the 21st Century.
Nast CC
Advances in chronic kidney disease 2017; (24(2)):72-79 doi:10.1053/j.ackd.2016.11.016.
PMID: 28284382 - 6
Facing the Challenge of Drug-Induced Acute Interstitial Nephritis.
Sanchez-Alamo B, Cases-Corona C, Fernandez-Juarez G
Nephron 2023; (147(2)):78-90 doi:10.1159/000525561.
PMID: 35830831 - 7
Use of Biologic Therapy in AA Amyloidosis Patients Undergoing Dialysis-A Systematic Literature Review.
Torun ES, Kadıoğlu G
Hemodialysis international. International Symposium on Home Hemodialysis 2025; (29(4)):450-462 doi:10.1111/hdi.13238.
PMID: 40152016 - 8
Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes.
Garrouste C, Anglicheau D, Kamar N, et al.
Medicine 2016; (95(41)):e5108 doi:10.1097/MD.0000000000005108.
PMID: 27741127 - 9
Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
Lane T, Gillmore JD, Wechalekar AD, et al.
Clinical and experimental rheumatology 2015; (33(6 Suppl 94)):S46-53.
PMID: 26120866 - 10
Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study.
Esatoglu SN, Hatemi G, Ugurlu S, et al.
Medicine 2017; (96(34)):e7859 doi:10.1097/MD.0000000000007859.
PMID: 28834898 - 11
A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.
Pamuk ÖN, Kalyoncu U, Aksu K, et al.
Rheumatology international 2016; (36(7)):945-53 doi:10.1007/s00296-016-3500-9.
PMID: 27221456 - 12
First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan.
Okuda Y, Yamada T, Ueda M, Ando Y
Internal medicine (Tokyo, Japan) 2018; (57(23)):3351-3355 doi:10.2169/internalmedicine.1099-18.
PMID: 30101921 - 13
Intestinal involvement in amyloidosis is a sequential process.
den Braber-Ymker M, Heijker S, Lammens M, et al.
Neurogastroenterology and motility 2018; (30(12)):e13469 doi:10.1111/nmo.13469.
PMID: 30230124
This page is for informational purposes only and does not constitute medical advice. If symptoms of AA amyloidosis are new or rapidly worsening, contact your specialty team or seek emergency care rather than relying on this page.
Get notified when new evidence is published on AA amyloidosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.